Scisparc Share Price Today
(NASDAQ: SPRC)

Name: Scisparc Share Price Today (NASDAQ: SPRC) - Scisparc Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Scisparc share price is $0.33 & ₹28.70 as on 6 Mar 2025, 2.30 'hrs' IST

$0.33

Market is closed - opens 8 PM, 06 Mar 2025

View live Scisparc share price in Dollar and Rupees. Guide to invest in Scisparc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Scisparc, along with analyst recommendations, forecasts, and comprehensive financials.

Scisparc share price movements

Today's Low: $0.32
Today's High: $0.33
$0.33
3.94%
Downside
Day's Volatility :4.55%
Upside
0.63%
52 Weeks Low: $0.20
52 Weeks High: $3.86
$0.33
40.3%
Downside
52 Weeks Volatility :94.9%
Upside
91.46%

Scisparc (SPRC) Returns

Period	Scisparc Ltd	Index (Russel 2000)
3 Months	45.96%	0.0%
6 Months	0.06%	0.0%
1 Year	-90.92%	0.0%
3 Years	-99.7%	-11.6%

Scisparc (SPRC) Key Statistics

in dollars & INR

Previous Close	$0.324901
Open	$0.32
Today's High	$0.3321
Today's Low	$0.317
Market Capitalization	$3.5M
Today's Volume	$22.6K
52 Week High	$3.8624
52 Week Low	$0.197
Revenue TTM	$1.7M
EBITDA	$-5.9M
Earnings Per Share (EPS)	$-5.28
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-85.91%

How to invest in Scisparc Stock (SPRC) from India?

It is very easy for Indian residents to invest directly in Scisparc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Scisparc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Scisparc or SPRC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Scisparc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Scisparc shares which would translate to 2.635 fractional shares of Scisparc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Scisparc, in just a few clicks!

Returns in Scisparc (SPRC) for Indian investors in Rupees

The Scisparc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Scisparc investment value today

Current value as on today

₹14,181

Returns

₹85,819

(-85.82%)

Returns from Scisparc Stock

₹90,782 (-90.78%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Scisparc (SPRC)

-87%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Scisparc Stock from India on INDmoney has decreased by -87% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Scisparc

UBS Group AG
0.49%
TWO SIGMA SECURITIES, LLC
0.37%
Susquehanna International Group, LLP
0.30%
Rhumbline Advisers
0.03%

Analyst Recommendation on Scisparc

Insights on Scisparc Stock (Ticker Symbol: SPRC)

Price Movement
In the last 3 months, SPRC stock has moved up by 46.0%
SPRC vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 153.4%
SPRC vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 147.4%
Price to Sales
ForSPRC every $1 of sales, investors are willing to pay $0.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

SPRC Scisparc Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$838.0K	↑ 72.07%
Net Income	$-8.5M	↑ 36.5%
Net Profit Margin	-1.0K%	↑ 265.08%

	FY19	Y/Y Change
Revenue	$498.0K	↓ 40.57%
Net Income	$-5.4M	↓ 37.09%
Net Profit Margin	-1.1K%	↓ 59.65%

	FY20	Y/Y Change
Revenue	$550.0K	↑ 10.44%
Net Income	$-3.5M	↓ 34.6%
Net Profit Margin	-637.64%	↑ 439.07%

	FY21	Y/Y Change
Revenue	$1.1M	↑ 94.36%
Net Income	$-5.8M	↑ 65.41%
Net Profit Margin	-542.66%	↑ 94.98%

	FY22	Y/Y Change
Revenue	$1.3M	↑ 26.01%
Net Income	$-2.6M	↓ 55.32%
Net Profit Margin	-192.43%	↑ 350.23%

	FY23	Y/Y Change
Revenue	$2.9M	↑ 113.73%
Net Income	$-5.1M	↑ 97.61%
Net Profit Margin	-177.91%	↑ 14.52%

	Q1 FY23	Q/Q Change
Revenue	$1.3M	-
Net Income	$3.2M	-
Net Profit Margin	235.12%	-

	Q2 FY23	Q/Q Change
Revenue	$2.0M	↑ 46.4%
Net Income	$-2.9M	↓ 190.94%
Net Profit Margin	-146.04%	↓ 381.16%

	Q1 FY24	Q/Q Change
Revenue	$907.0K	↓ 54.01%
Net Income	$-2.2M	↓ 22.15%
Net Profit Margin	-247.19%	↓ 101.15%

	FY18	Y/Y Change
Profit	$691.0K	↑ 43.36%

	FY19	Y/Y Change
Profit	$319.0K	↓ 53.84%

	FY20	Y/Y Change
Profit	$386.0K	↑ 21.0%

	FY21	Y/Y Change
Profit	$1.0M	↑ 168.39%

	FY22	Y/Y Change
Profit	$1.0M	↓ 1.06%

	FY23	Y/Y Change
Profit	$2.2M	↑ 114.24%

	Q2 FY22	Q/Q Change
Profit	$-21.0K	↓ 102.03%

	Q1 FY23	Q/Q Change
Profit	$1.0M	-

	Q2 FY23	Q/Q Change
Profit	$705.0K	↓ 31.22%

	Q1 FY24	Q/Q Change
Profit	$323.0K	↓ 54.18%

	FY18	Y/Y Change
Operating Cash Flow	$-7.1M	↑ 55.75%
Investing Cash Flow	$-2.1M	↑ 3850.94%
Financing Cash Flow	$1.5M	↓ 88.34%

	FY19	Y/Y Change
Operating Cash Flow	$-4.7M	↓ 34.16%
Investing Cash Flow	$1.3M	↓ 160.55%
Financing Cash Flow	$2.8M	↑ 82.55%

	FY20	Y/Y Change
Operating Cash Flow	$-4.3M	↓ 8.28%
Investing Cash Flow	$24.0K	↓ 98.11%
Financing Cash Flow	$5.4M	↑ 91.12%

	FY21	Y/Y Change
Operating Cash Flow	$-5.1M	↑ 17.51%
Investing Cash Flow	$-70.0K	↓ 391.67%
Financing Cash Flow	$10.1M	↑ 87.72%

	FY22	Y/Y Change
Operating Cash Flow	$-7.9M	↑ 56.43%
Investing Cash Flow	$-7.1M	↑ 10020.0%
Financing Cash Flow	$11.7M	↑ 16.3%

	Q3 FY22	Q/Q Change
Operating Cash Flow	$-2.9M	↑ 30.92%
Investing Cash Flow	$-3.2M	-
Financing Cash Flow	$1.4M	↓ 84.75%

	Q4 FY22	Q/Q Change
Operating Cash Flow	$-2.9M	↑ 0.0%
Investing Cash Flow	$-3.2M	↑ 0.0%
Financing Cash Flow	$1.4M	↑ 0.0%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-5.7M	↑ 100.0%
Investing Cash Flow	$-535.5K	↓ 83.2%
Financing Cash Flow	$2.7M	↑ 100.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-3.2M	↓ 43.57%
Investing Cash Flow	$-535.5K	↑ 0.0%
Financing Cash Flow	$2.8M	↑ 2.82%

Scisparc Technicals Summary

Sell

Neutral

Buy

Scisparc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Scisparc (SPRC) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Scisparc Ltd	-26.51%	0.06%	-90.92%	-99.7%	-99.82%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Scisparc Ltd	0.0	NA	NA	0.0	-0.86	-0.39	NA	1.93
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Scisparc Ltd	NA	$3.5M	-99.82%	0.0	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Scisparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

Organization	Scisparc
Employees	3
CEO	Mr. Oz Adler CPA
Industry	Miscellaneous

Management People of Scisparc

Name	Title
Mr. Oz Adler CPA	CEO & CFO
Mr. Itschak Shrem	President & Director
Dr. Adi Zuloff-Shani Ph.D.	Chief Technologies Officer

Important FAQs about investing in SPRC Stock from India :

What is Scisparc share price today?

Scisparc share price today stands at $0.33, Open: $0.32 ; Previous Close: $0.32 ; High: $0.33 ; Low: $0.32 ; 52 Week High: $3.86 ; 52 Week Low: $0.20.

The stock opens at $0.32, after a previous close of $0.32. The stock reached a daily high of $0.33 and a low of $0.32, with a 52-week high of $3.86 and a 52-week low of $0.20.

Can Indians buy Scisparc shares?

Yes, Indians can invest in the Scisparc (SPRC) from India.

With INDmoney, you can buy Scisparc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Scisparc at zero transaction cost.

How can I buy Scisparc shares from India?

It is very easy to buy Scisparc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Scisparc (SPRC) be purchased?

Yes, you can buy fractional shares of Scisparc with INDmoney app.

What are the documents required to start investing in Scisparc stocks?

To start investing in Scisparc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.